TY  - BOOK
TI  - Comparative Study of Select Indian Pharmaceutical Companies Performance Before and During the Covid 19 Pandemic
U1  - WIN/2022/FIN-SPE/PR4991 
PY  - 2022///
CY  - Mumbai
PB  - SFIMAR
KW  - FIN-SPE
KW  -  Indian Pharmaceutical Companies
ER  -